北京圣永制药

Beijing Shengyong Pharmaceutical is a modern high-tech pharmaceutical company established in 2000 and based in Beijing, China. The company integrates research and development, manufacturing, and sales of chemical drug formulations. Its core commercial products include Junlida (Metformin Hydrochloride Enteric-coated Capsules) for the treatment of type 2 diabetes and obesity, and Shengyong Changqing (Polyethylene Glycol Electrolyte Oral Solution) used for bowel cleansing prior to colonoscopy or surgery. Beijing Shengyong Pharmaceutical operates GMP-certified manufacturing facilities in Tongzhou District, Beijing, and continues to expand its product portfolio through generic drug development and consistency evaluations.